v3.26.1
Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-In
Capital
Accumulated
Other Comprehensive Loss
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2024 29,084,235        
Beginning balance at Dec. 31, 2024 $ 419,409        
Ending balance (in shares) at Mar. 31, 2025 29,084,235        
Ending balance at Mar. 31, 2025 $ 419,409        
Beginning balance (in shares) at Dec. 31, 2024   10,925,950      
Beginning balance at Dec. 31, 2024 (251,656) $ 0 $ 30,545 $ 0 $ (282,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   130,387      
Issuance of common stock upon exercise of stock options 365   365    
Stock-based compensation 2,374   2,374    
Net income (loss) (3,988)       (3,988)
Ending balance (in shares) at Mar. 31, 2025   11,056,337      
Ending balance at Mar. 31, 2025 $ (252,905) $ 0 33,284 0 (286,189)
Beginning balance (in shares) at Dec. 31, 2025 0        
Beginning balance at Dec. 31, 2025 $ 0        
Ending balance (in shares) at Mar. 31, 2026 0        
Ending balance at Mar. 31, 2026 $ 0        
Beginning balance (in shares) at Dec. 31, 2025   45,804,755      
Beginning balance at Dec. 31, 2025 $ 480,105 $ 0 756,644 (1,792) (274,747)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 176,137 176,137      
Issuance of common stock upon exercise of stock options $ 1,255   1,255    
Stock-based compensation 6,290   6,290    
Net income (loss) 17,970       17,970
Ending balance (in shares) at Mar. 31, 2026   45,980,892      
Ending balance at Mar. 31, 2026 $ 505,620 $ 0 $ 764,189 $ (1,792) $ (256,777)